Apologies, but no results were found for the requested archive. Perhaps searching will help find a related post.
Gene MD focuses on biotechnology and device companies developing therapies for cancer, cardiovascular disease, autoimmune diseases, and neurodegeneration.
Author: James W. Hill, MD
Nothing posted here constitutes legal, medical, or investment advice.
Your comments are welcome.
- Notice of Completion of Acquisition of Own Shares (pdf 41KB) phrmwb.com/1K7MGDG #pharminews - 9 hours ago
- Notice of Zealand’s Interim Report for H1 2015 and related conference call phrmwb.com/1KPHiiS #pharminews - 11 hours ago
- VALNEVA Valneva Announces Two New EB66(R) Agreements phrmwb.com/1KPHgr9 #pharminews - 11 hours ago
- Data Published in The New England Journal of Medicine Shows Daratumumab Monotherapy Induced Durabl... phrmwb.com/1KPHgaS #pharminews - 11 hours ago
- VALNEVA Valneva Announces Two New EB66® Agreements phrmwb.com/1KPHiiL #pharminews - 11 hours ago